The ras family of oncogenes is one of a group of cellular oncogenes initially identified by virtue of their homology to sequences present in acutely transforming oncogenic retroviruses (Bishop, 1983) . Several such oncogenes have been identified as the transforming genes in biological transfection assays, and abnormal oncogene activity at either a qualitative or quantitative level has been shown in a variety of human tumours (Cooper, 1984) .
Activation of members of the ras family of oncogenes (comprising Kirsten, Harvey and N-ras) has been demonstrated in a variety of tumours including carcinomas (eg lung, colon, bladder) , tumours of neural origin (eg melanoma, neuroblastoma) as well as in certain lymphoid neoplasia (for a review see Balmain, 1985) . In some of these cases activation appears to be associated with mutations most commonly involving 'hot spots' around codons 12 and 61. The exact significance of ras oncogene activity in carcinogenesis or the stage(s) at which this may be critical remains, however, far from clear. Although active transforming ras genes were initially identified in frankly malignant tumours we have demonstrated activated Ha-ras in carcinogen induced premalignant mouse skin papillomas (Balmain et al., 1984) and we have also shown elevated expression of ras family oncogenes in pre-malignant as well as in malignant tumours of the colorectum (Spandidos & Kerr, 1984) .
Similarly, little is known of the physiological role of the ras oncogene p21 protein products. They are known to comprise a family of proteins of Mol. Wt. 21-24 kilodaltons and to be located on the cytoplasmic side of the cell membrane (Willingham et al., 1980) . They possess GTP-binding (Shih et al., 1979) and GTP-ase (Sweet et al., 1984) activity and show homology with the 'G' protein which regulates hormone sensitive adenylate cyclase activity (Gilman, 1984) . GTP dependent phosphorylation of p21 has been shown to be stimulated by both EGF and insulin (Kamata & Feramisco, 1984) . The half-life of the cellular p21 in vitro is of the order of 20h (Ulsh & Shih, 1984) . Widespread transcription of ras genes has been documented in embryogenesis (Muller et al., 1983) and increased transcription is seen in regenerating liver (Goyette et al., 1984) . It is thought therefore that the role of ras family oncogenes may well be in the control of cell proliferation, possibly as signal transducers for growth factors.
Although we have previously demonstrated an overall elevated expression of ras genes in total cellular RNA in tissue homogenates from premalignant polyps and malignant carcinomas of the colerectum relative to normal mucosa it was clearly impossible to know whether particular cell subpopulations might have been responsible for the transcripts present. We have therefore now attempted to define cell populations of the colorectum in both normal and pathological states which contain the translated p21 protein by immunocytochemical means, using the anti-p21 monoclonal antibody Y13-259 (Furth et al., 1982) In order to confirm antibody specificity, overnight cultures on cover slips of NIH3T3 cells and SEP14 transformants generated by transfection with mouse papilloma Ha-ras DNA (Balmain et al., 1984) were stained as above.
Immunoprecipitation of the ras-p21 species present in the transfectants was also performed following metabolic labelling with [35S] methionine and extraction with lysis buffer (Shih et al., 1980) . The extract was precleared with protein Asepharose precoated with rabbit anti-rat immunoglobulin G and incubated with either the Y13-259 or YA6-172 antibodies. The antigen-antibody complexes were collected with protein-A-sepharose precoated rabbit anti-rat immunoglobulin G and the precipitates were washed and subjected to electrophoresis on 12.5% polyacrylamide gels (Laemmli, 1970) . Protein bands were identified by fluorography.
Results
The pattern of immunoperoxidase reactivity seen in our series is illustrated in Figure 1 . It can be seen that there is a relatively weak but apparently uniform staining of the epithelial cells in both normal adult (Figure la-c) and foetal (Figure Id) colorectal crypts extending from the bases (where the proliferating stem cells are located) to the luminal surface. A similar pattern was seen in the adenomatous polyps ( Figure 1f ) and carcinomas (Figure Ig) where some variability in the intensity of staining within and between tumours was seen, although this was difficult to reproduce. In both polyps and carcinomas however, staining did appear to be more intense, although this was perhaps partly due to the localisation of the staining. In both adenomas and carcinomas this appeared to be clearly cytoplasmic, whilst there was an impression that in the normal mucosa the staining was confined more to the cell membrane, although this was difficult to interpret due to the presence of intracellular mucin. All cases of tumour examined exhibited a similar pattern of slightly variable reactivity which was unrelated to histological appearance. Samples of mucosa and polyps from a case of polyposis coli showed a similar appearance (not shown). The biopsies of a case of fulminant ulcerative colitis (Figure le) also showed uniform positive staining regardless of the degree of epithelial dysplasia. The samples of metastatic carcinoma examined from liver ( Figure  Ih ) and lymph node (not shown) again showed broadly positive staining. Interestingly, however, the hepatocytes surrounding the metastatic tumour stained consistently more intensely than the cancer cells (not shown).
We observed in our series a faint staining of stromal connective tissue with, however, clear staining of nerve fibres in the enteric ganglia. Although bowel wall muscle fibres in the adult do not stain convincingly those in the section of foetal large bowel showed marked positivity (Figure ld) . Lymphoid follicles and cells of haematopoietic lineage occasionally seen in the sections did not stain at all.
A similar, although less intense, pattern of staining was seen in our series using the monoclonal antibody Y6-172 (Furth et al., 1982) .
The pattern of staining seen did not differ when these antibodies were tested over a range of dilutions from 1/50 to 1/500. All of our specimens were stained following frozen section since in our hands reactivity using acid or neutral formalin-fixed paraffin sections was not seen, even after trypsinisation.
Specificity of staining was confirmed by the reactivity of these antibodies with NIH3T3 cells before, and after (SEP14) transfection with an Ha ras oncogene. Clear positivity is seen in the majority of transfectants whereas background levels of staining only are seen in the 3T3 cells ( Figure  2a, b) . Similarly, the results of immunoprecipitation of the ras p21 contained in the transfectants (Figure 3) show two bands precipitated by Y13-259 in lane 3.
These correspond to the endogenous Ki-ras p21 (slower mobility) and the exogenous Ha-ras p21 (faster mobility). YA6-172 precipitates only Ha-ras p21 in mouse cells as shown by the single band in lane 1.
Discussion
On the basis of available evidence activity of cellular ras proto-oncogenes has hitherto been putatively associated with cell growth and proliferation and, in an activated oncogenic form, with carcinogenesis (Balmain, 1985) . Our results, however, suggest that production of the p21 ras encoded protein as detected by the monoclonal antibody Y13-259 is not restricted to cells which are actively growing or dividing, either in normal mucosa or in tumours where, although identification of clonogenic tumour stem cells is much less easy, the fact that their growth fraction is only in the region of 15% (Wright, 1984) indicates that the pattern of staining observed cannot be ascribed to them alone. In normal crypts the epithelial cell survival time is of the order of 4-8 days (Wright, 1984) whereas the results of in vitro experiments suggest that the half-life of the c-Ha-ras p21 is only 20 h, (Ulsh & Shih, 1984 ) although this may not be the case in vivo.
Although both benign and malignant tumours appear to stain rather more intensely than normal mucosa it is difficult to interpret the biological significance of this due to the virtual 'all or nothing' nature of such immunocytochemical reactivity, which effectively precludes meaningful quantitation of staining, (see Docherty, 1984) . In addition, these antibodies appear to react relatively weakly with tissue sections.
Nonetheless it appears that the immunological demonstration of the ras encoded p21 protein does not differentially identify particular subpopulations of cells either involved in cell proliferation nor any present in specimens of adenomas or ulcerative colitis, both recognised to be premalignant conditions (see Morson & Dawson, 1979) , which might have particular malignant potential. Similarly, subpopulations of cancer cells which may have, for example, an increased metastatic potential obviously can not be identified by these techniques.
We have previously shown elevated levels of ras family oncogene expression in premalignant and malignant tumours of the colorectum and suggested that elevated expression of ras genes may be critical in the process of carcinogenesis but not in itself sufficient. Our present results are certainly not inconsistent with such an interpretation. These suggest, however, that immunocytochemical study of p21 distribution with this antibody will contribute little to a more accurate assessment of stages of carcinogenesis or of variations of the malignant phenotype. It is of course the case that expression of variously mutated p21's in a cell population or sub-population which might be significant would not be detected using this particular antibody (which reacts broadly with both Ha-and Ki-ras p21 products) and the development of antibodies directed to particular mutated epitopes would be required to define them. Similarly the significance of the apparent cytoplasmic localisation of the p21 in tumours when the normal p21 is reported as being membrane-associated (Willingham et al., 1980) is not clear, and its interpretation will await the results of ultrastructural study which we are currently undertaking.
During the course of this study reports have appeared of the reactivity of a further series of anti p21 antibodies (RAP 1-5) raised against synthetic ras peptides corresponding to the region around codon 12, with formalin-fixed paraffin-processed sections of breast (Hand et al., 1984) and colon (Thor et al., 1984) carcinomas. These showed a heterogeneous pattern of staining, which was seen, however, in only a few benign lesions and not in normal epithelium. Reactivity with cryostat sections was not reported. It was therefore suggested that such reactivity may be a useful marker of stages of carcinogenesis.
The reason for the discrepancies in reactivity seen is not at all clear since neither the Y13-259 nor RAP 1-5 antibodies can distinguish normal from mutated p21 immunocytochemically. It is possible that there may be selective presentation of the epitope recognised by the RAP antibodies in associated with malignant transformation. Alternatively, the heterogenous reactivity seen with these antibodies may represent a quantitative phenomenon with lesser amounts of antigen not being seen due to loss of antigen in processing, a phenomenon well-recognised in immunocytochemistry (see Polak & van Noorden, 1983) . Indeed in our previous studies we observed elevated levels of ras RNA transcription in a series of colorectal carcinomas relative to normal mucosa (Spandidos & Kerr, 1984) which would be consistent with such a hypothesis. In that study however, even higher levels of RNA transcription were seen in several adenomata which appear to show minimal reactivity with the RAP antibodies.
Our present results, in any case, seem to suggest that production of at least some p21 is a feature of normal cellular metabolism in certain cell types and that reactivity with the Y13-259 antibody is not helpful in defining either cells at different stages of carcinogenesis nor those representing variants of a malignant phenotype.
